BioSpace News Archive

Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced the close of a US$126 million Series A financing round.

Spectrum Chemical Mfg. Corp. has entered into a new distribution arrangement with ANGUS Chemical Company that expands Spectrum Chemical’s product offerings for research and development and production scale-up at commercial and academic organizations serving the biopharmaceutical and life sciences industries in the United States and Canada.

BIOLASE, Inc., the global leader in dental lasers is proud to host its first annual meeting of leading dental laser experts on June 10, 2022 and June 11, 2022 at the Avenue of the Arts in Costa Mesa, CA.

Avivagen Inc. is pleased to announce that it has completed a series of important safety evaluations of fully oxidized beta-carotene, the proprietary and critical active ingredient in the company’s highly-regarded OxC-beta™ product line.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced data from three oral presentations at the 2022 American Transplant Congress by faculty at the Center for Transplantation Sciences, Massachusetts General Hospital.

Tiziana Life Sciences Ltd. announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 18,000 common shares at $0.80 per share.

Exavir Therapeutics, a company dedicated to transforming the lives of patients living with or at risk of acquiring HIV and other viral infections, announced today the publication of preclinical data for XVIR-120, an investigational agent being developed as a long-acting injectable antiviral for HIV treatment and prophylaxis.

New analyses showing AYVAKIT® (avapritinib) significantly improved overall survival in advanced SM, when indirectly compared to real-world data for prior standard therapies, to be presented at EHA 2022 Congress.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate in a fireside chat at The JMP Securities Life Sciences Conference on June 16, 2022 at 1:00 p.m. ET in New York, NY.

Molecular Targeting Technologies, Inc. (MTTI), a clinical stage oncology company, will highlight advances on its EvaThera TM radiotheranostics platform at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Vancouver, BC, on June 11-15, 2022.